Skip to main content
Guhan Pharmaceutical Group Co., Ltd. logo

Guhan Pharmaceutical Group Co., Ltd. — Investor Relations & Filings

Ticker · 000590 ISIN · CNE000000701 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,714 across all filing types
Latest filing 2019-08-28 Interim / Quarterly Rep…
Country CN China
Listing Shenzhen Stock Exchange 000590

About Guhan Pharmaceutical Group Co., Ltd.

https://www.tuspharma.cn

Guhan Pharmaceutical Group Co., Ltd. specializes in the research, development, production, and sale of traditional Chinese medicine (TCM) and health-related products. The company is widely recognized for its flagship product, Guhan Yangsheng Jing, which is formulated based on ancient health preservation prescriptions discovered in the Mawangdui Han Dynasty Tombs. Its product portfolio includes oral liquids, tablets, and capsules designed to enhance vitality, support kidney function, and promote overall longevity. The organization integrates classical medical theories with modern pharmaceutical manufacturing processes to ensure product efficacy and safety. Beyond its core TCM offerings, the group engages in the production of chemical drugs and health supplements, targeting markets seeking natural wellness solutions. The company emphasizes the preservation of cultural heritage through the modernization of ancient medical wisdom.

Recent filings

Filing Released Lang Actions
2019年半年度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "启迪古汉集团股份有限公司 2019 年半年度报告全文" which translates to "TUS-GUHAN Group Corp., Ltd. 2019 Semi-Annual Report Full Text." It contains detailed financial data, business overview, management discussion and analysis, financial indicators, and other comprehensive information typical of an interim or quarterly report. The report period is clearly stated as January 1, 2019 to June 30, 2019, confirming it covers a half-year period. The document is about 15,000 characters long, indicating it is a full report rather than a brief announcement. It includes financial statements, management analysis, business overview, and risk disclosures, which are characteristic of an Interim / Quarterly Report (IR). There is no indication that this is an annual report (10-K), audit report (AR), or any other filing type. Therefore, the document is best classified as an Interim / Quarterly Report (IR). H1 2019
2019-08-28 Chinese
2019年半年度财务报告
Interim / Quarterly Report Classification · 100% confidence The document is titled as the 2019 semi-annual financial report (半年度财务报告) of 启迪古汉集团股份有限公司, which indicates it is a financial report for a period shorter than a full fiscal year. The content includes detailed consolidated financial statements such as the balance sheet, income statement, cash flow statement, and changes in equity, along with notes on accounting policies and company background. The length is substantial (15,000 characters) and contains actual financial data and analysis, not just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). H1 2019
2019-08-28 Chinese
2019年半年度报告摘要
Interim / Quarterly Report Classification · 100% confidence The document is titled as a '2019 年半年度报告摘要' which translates to '2019 Semi-Annual Report Summary'. It contains detailed financial data for the half-year period, including revenue, net profit, earnings per share, and asset information. It also discusses changes in accounting policies, financial instruments, and operational analysis for the period. The length of the document (5562 characters) and the presence of substantive financial data and analysis confirm it is a financial report rather than a brief announcement or certification. The document is a comprehensive interim/quarterly report covering a period shorter than a full fiscal year, consistent with the definition of an Interim / Quarterly Report (IR). H1 2019
2019-08-28 Chinese
关于2019年半年度募集资金存放与使用情况的专项报告
Capital/Financing Update Classification · 95% confidence The document is a detailed report on the use and management of funds raised through a non-public stock issuance by 启迪古汉集团股份有限公司. It includes specifics on the amount raised, the timing of fund receipt, usage amounts over multiple years including the current half-year period ending June 30, 2019, and the balance remaining. It also discusses the management system for the funds, bank accounts used, regulatory compliance, and investment of idle funds in financial products. The document contains tables with detailed financial figures related to the raised funds and their deployment in various projects, including changes and project progress updates. The document is titled as a "专项报告" (special report) on the half-year usage of raised funds, and it is not a general annual or interim financial report, nor an earnings release or management discussion. It is a specialized disclosure related to capital raised and its usage, consistent with a Capital/Financing Update filing. The length (over 8,000 characters) and detailed financial data confirm it is a substantive report, not merely an announcement or certification. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2019-08-28 Chinese
第八届董事会临时会议独立董事意见
Board/Management Information Classification · 95% confidence The document is an independent directors' opinion issued during a board meeting of 启迪古汉集团股份有限公司. It discusses specific issues such as related party transactions, use of raised funds, and accounting policy changes. The content is focused on board-level oversight and opinions rather than full financial statements or earnings data. The document length is short (1210 characters), and it is not a full report but an opinion statement related to board matters. Therefore, it fits best under Board/Management Information (MANG), which covers announcements related to board or senior management activities and opinions.
2019-08-28 Chinese
关于更换持续督导保荐代表人的公告
Board/Management Information Classification · 95% confidence The document is an announcement regarding the change of the continuous supervision sponsor representative for a company's non-public stock issuance project. It details the replacement of a sponsor representative due to work changes and the continuation of supervision responsibilities related to the use of raised funds. The document is short (1069 characters) and serves as a formal notification of a management-related change rather than a financial report or detailed filing. It does not contain financial statements, audit information, or detailed report data. Therefore, it fits best under Board/Management Information (MANG), which covers announcements of changes in company board or senior management roles, including sponsor representatives in financing projects.
2019-08-22 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.